Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech portfolio.

Telix states its automated and high-throughput generator can produce sufficient lead-212 elution for up to 60 clinical doses, ...

Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

Atsena Therapeutics has received fast track designation from the FDA for ATSN-201, aimed at treating X-linked retinoschisis ...

Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat polycythemia ...

Silgan Dispensing goes to great lengths to protect and preserve your formulation through state-of-the art engineering while making sure your customers can easily and reliably dispense the right dose.

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-based AbTis to advance next-generation ADCs.

Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care offerings in the US ...

The specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain ...

Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.

Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.